FirstString Research

FirstString Research operates as a biopharmaceutical company that discovers and develops therapies for inflammation-based medical conditions. Since its founding in 2005, FirstString has worked to develop and commercialize therapeutic products that enable physicians to treat unmet medical needs. The company’s therapeutic approach focuses on mitigating excessive inflammation, calming the inflamed tissue, and rebooting the body’s normal injury response mechanism to allow the healing process to become engaged. FirstString Research also has a strategic collaboration with Relief Therapeutics SA.

Investment: $712,500

Address: 300 West Coleman Blvd., Suite 203

Mount Pleasant, SC 29464

Email: info@firststringresearch.com 

Phone: (843) 860-8372

Health Care, Therapeutics, Medical Research, R&D, B2B